In March 2021, Curaleaf Holdings, one of the largest cannabis companies in the United States, acquired EMMAC Life Sciences Group (now Curaleaf International), one of the largest vertically integrated companies in the European medical cannabis landscape.
Curaleaf International was created by combining EMMAC’s scientific approach with Curaleaf’s expertise from the consumer side.
Given his experience in the medical cannabis industry, Antonio Costanzo has noticed clear progress in the market. He also thinks European countries will allow the use of recreational cannabis in the next four years.